Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

investors.amgen.com

Amgen News Release

Get the latest updates from Amgen News Release directly as they happen.

Follow now 90 followers

Latest posts

Last updated over 1 year ago

Amgen and UCB Provide Regulatory Update on Status of EVENITY™ (romosozumab) in the EU

over 1 year ago

THOUSAND OAKS, Calif. and BRUSSELS, June 27, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN)...

Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket

over 1 year ago

Two Biotherapeutic Companies Receive Lab Space and Other Benefits to Further Advance...

Amgen And The Institute For Protein Design (IPD) At University Of Washington Announce Unique Strategic Research Partnership

over 1 year ago

Collaboration Will Apply IPD's de novo Protein Design Expertise to Biotech Drug...

Amgen Announces BLINCYTO® (blinatumomab) Five-Year Overall Survival Data At EHA 2019

over 1 year ago

Phase 2 Single-Arm BLAST Study Shows Median Overall Survival of 36.5 Months...

FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab)

over 1 year ago

Approval Based on Totality of Evidence Demonstrating KANJINTI is Biosimilar to Herceptin...

Amgen Publishes Offer Document With Respect To The Recommended Public Cash Offer To The Shareholders Of Nuevolution

over 1 year ago

THOUSAND OAKS, Calif., June 12, 2019 /PRNewswire/ -- The Offer is not...

Intermountain Healthcare and deCODE genetics Launch Groundbreaking DNA Study of 500,000 People to Find New Links Between Genetics and Disease

over 1 year ago

Study Represents Largest  DNA Mapping Effort Undertaken in U.S. from a Single...

Amgen To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

over 1 year ago

THOUSAND OAKS, Calif., June 7, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present...

Amgen Announces First Clinical Data Evaluating Novel Investigational KRASG12C Inhibitor AMG 510 At ASCO 2019

over 1 year ago

AMG 510 is the First KRASG12C Inhibitor to Reach Clinical Stage After...

Amgen Highlights The Versatility Of The BiTE® Immuno-Oncology Platform In Multiple Tumor Types At ASCO 2019

over 1 year ago

Updated Phase 1 Data of Investigational AMG 420 in Relapsed and/or Refractory...

Amgen To Webcast Investor Meeting At 55th Annual Meeting Of The American Society Of Clinical Oncology (ASCO)

over 1 year ago

THOUSAND OAKS, Calif., May 29, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will...

Additional Irrevocable Undertakings To Accept Amgen's Recommended Public Cash Offer To The Shareholders Of Nuevolution

over 1 year ago

THOUSAND OAKS, Calif., May 28, 2019 /PRNewswire/ --  The Offer is not...